Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats

de Boer, 2003, The role of drug transporters at the blood–brain barrier, Annu. Rev. Pharmacol. Toxicol., 43, 629, 10.1146/annurev.pharmtox.43.100901.140204 Dobrogowska, 1999, Quantitative immunocytochemical study of blood–brain barrier glucose transporter (GLUT-1) in four regions of mouse brain, J. Histochem. Cytochem., 47, 1021, 10.1177/002215549904700806 Dombrowski, 2001, Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy, Epilepsia, 42, 1501, 10.1046/j.1528-1157.2001.12301.x Farrell, 1991, Blood–brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial luminal and abluminal membranes: an electron microscopic immunogold study, Proc. Natl. Acad. Sci. USA, 88, 5779, 10.1073/pnas.88.13.5779 Kim, 1997, Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells, Am. J. Physiol., 273, C687, 10.1152/ajpcell.1997.273.2.C687 Lee, 2001, Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations, Pharmacol. Rev., 53, 569, 10.1146/annurev.pharmtox.41.1.569 Löscher, 1997, Animal models of intractable epilepsy, Prog. Neurobiol., 53, 239, 10.1016/S0301-0082(97)00035-X Löscher, 2002, Current status and future directions in the pharmacotherapy of epilepsy, Trends Pharmacol. Sci., 23, 113, 10.1016/S0165-6147(00)01974-X Löscher, 1996, Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy, Epilepsy Res., 11, 17 Löscher, 2002, Role of multidrug transporters in pharmacoresistance to antiepileptic drugs, J. Pharmacol. Exp. Ther., 301, 7, 10.1124/jpet.301.1.7 Paxinos, G., Watson, C., 1998. The rat brain in stereotaxic coordinates, fourth ed. Academic Press, Sydney. Potschka, 2002, A comparison of extracellular levels of phenytoin in amygdala and hippocampus of kindled and non-kindled rats, Neuroreport, 13, 167, 10.1097/00001756-200201210-00038 Racine, 1972, Modification of seizure activity by electrical stimulation: II. Motor seizure, Electroencephgr. Clin. Neurophysiol., 32, 281, 10.1016/0013-4694(72)90177-0 Rajagopal, 2003, Subcellular localization and activity of multidrug resistance proteins, Mol. Biol. Cell, 14, 3389, 10.1091/mbc.E02-11-0704 Regesta, 1999, Clinical aspects and biological bases of drug-resistant epilepsies, Epilepsy Res., 34, 109, 10.1016/S0920-1211(98)00106-5 Rieux, 2002, Analysis of immunohistochemical label of Fos protein in the suprachiasmatic nucleus: comparison of different methods of quantification, J. Biol. Rhythms, 17, 121, 10.1177/074873002129002410 Rizzi, 2002, Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance, J. Neurosci., 22, 5833, 10.1523/JNEUROSCI.22-14-05833.2002 Rundfeldt, 1990, Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats, Neuropharmacology, 29, 845, 10.1016/0028-3908(90)90159-O Schinkel, 1999, P-glycoprotein, a gatekeeper in the blood–brain barrier, Adv. Drug Deliv. Rev., 36, 179, 10.1016/S0169-409X(98)00085-4 Seegers, 2002, Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats, Epilepsia, 43, 675, 10.1046/j.1528-1157.2002.33101.x Seegers, 2002, Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy, Epilepsy Res., 51, 257, 10.1016/S0920-1211(02)00156-0 Sisodiya, 1999, Over-expression of P-glycoprotein in malformations of cortical development, Neuroreport, 10, 3437, 10.1097/00001756-199911080-00032 Sisodiya, 2002, Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy, Brain, 125, 22, 10.1093/brain/awf002 Sisodiya, 2003, Widespread upregulation of drug-resistance proteins in fatal human status epilepticus, Epilepsia, 44, 261, 10.1046/j.1528-1157.2003.42802.x Tishler, 1995, MDR1 gene expression in brain of patients with medically intractable epilepsy, Epilepsia, 36, 1, 10.1111/j.1528-1157.1995.tb01657.x Wahnschaffe, 1992, Lack of changes in seizure susceptibility during the estrous cycle in kindled rats, Epilepsy Res., 13, 199, 10.1016/0920-1211(92)90053-V Willemse, 1993, Image analysis in immunohistochemistry. Factors with a possible influence on the performance of VIDAS version 2.0, a commercially available true color image analysis system, Anal. Quant. Cytol. Histol., 15, 136 Willemse, 1994, Quantification of area percentage of immunohistochemical staining by true color image analysis with application of fixed thresholds, Anal. Quant. Cytol. Histol., 16, 357 Wolf, 1996, NeuN: a useful neuronal marker for diagnostic histopathology, J. Histochem. Cytochem., 44, 1167, 10.1177/44.10.8813082 Zhang, 1999, Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections, Exp. Brain Res., 126, 509, 10.1007/s002210050759